Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis

OBJECTIVES Clinical reports have speculated on a more severe course of multiple sclerosis in patients with the apolipoprotein E (apoE) epsilon4 allele. As this could be reflected by differences in the severity of tissue damage MRI was used to obtain further support for a disease modifying effect of the apoE genotype. METHODS Brain MR scans of 83 patients (mean age 35.5 (SD 9.5 years) who participated in a cross sectional study on the distribution of genotype patterns in multiple sclerosis. The total lesion load on proton density weighted (T2-LL) and T1 weighted scans (T1-LL) obtained with conventional spin echo sequences at 1.5 T was measured. A "black hole" ratio ((T1-LL/T2-LL)x100) was also calculated. This indicates the proportion of multiple sclerosis lesions with more severe tissue damage and may reflect disease aggressiveness or quality of repair. RESULTS Patients with the apoE-epsilon3/epsilon4 genotype (n=19) showed a non-significantly greater T2-LL (16.0 (SD 14.0) cm(3)) than patients with the epsilon2/epsilon3 (n=11; 13.3 (9.5) cm(3)) or the epsilon3/epsilon3 genotype (n=49; 9.4 (SD 9.2) cm(3)). Both the T1-LL (2.6 (SD 3.3) v 1.6 (SD 2.4) and 1.2 (SD 3.0) cm(3); p=0.04) and the black hole ratio (14.3 SD 11.9) v 7.4 (SD 9.3) and 8.4 (SD 13.3)%; p=0.02), however, were significantly higher in epsilon3/epsilon4 patients. Similar differences were seen when comparing patients with at least one epsilon4 allele with the remainder of the group. CONCLUSIONS These data support speculations on a modulation of multiple sclerosis severity by the apoE genotype which can be attributed to more extensive tissue destruction or less efficient repair in carriers of the epsilon4 allele.

[1]  N. Evangelou,et al.  Association of the APOE ε4 allele with disease activity in multiple sclerosis , 1999, Journal of neurology, neurosurgery, and psychiatry.

[2]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[3]  C. Poser,et al.  The epidemiology of multiple sclerosis: A general overview , 1994, Annals of neurology.

[4]  R. Mahley,et al.  Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.

[5]  H. Tobi,et al.  Correlating MRI and clinical disease activity in multiple sclerosis , 1995, Neurology.

[6]  J. Chapman,et al.  Preliminary Observations on APOE ϵ4 Allele and Progression of Disability in Multiple Sclerosis , 1999 .

[7]  J Grimaud,et al.  Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis , 1998, Neurology.

[8]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[9]  R. Strange,et al.  Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis , 2000, Multiple sclerosis.

[10]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[11]  B. Weinshenker,et al.  The epidemiology of multiple sclerosis. , 1997, Mayo Clinic proceedings.

[12]  N. Risch,et al.  Evidence for genetic basis of multiple sclerosis , 1996, The Lancet.

[13]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[14]  F Barkhof,et al.  Neuronal damage in T1‐hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy , 1999, Annals of neurology.

[15]  R J Donaldson,et al.  A General Overview , 1980, Royal Society of Health journal.

[16]  Hans Lassmann,et al.  Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.

[17]  D. Rubinsztein,et al.  Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease. , 1994, Molecular and cellular probes.

[18]  F. Barkhof,et al.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.

[19]  B Bass,et al.  The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. , 1989, Brain : a journal of neurology.

[20]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.

[21]  B. Fontaine,et al.  Apolipoprotein E Polymorphism in Multiple Sclerosis , 1998, Annals of clinical biochemistry.

[22]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[23]  Richard D. Jones,et al.  Impairment and recovery of ipsilateral sensory-motor function following unilateral cerebral infarction. , 1989, Brain : a journal of neurology.

[24]  S. Reingold,et al.  The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.

[25]  E. Shooter,et al.  A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. , 1989, The Journal of clinical investigation.

[26]  S. Sawcer,et al.  Genetic analysis of multiple sclerosis. , 1997, Current neurology and neuroscience reports.